Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell-derived cardiomyocytes after acute myocardial infarction

Circulation

Volumn 132, Issue 8, 2015, Pages 762-771

  Ong, Sang Ging ^a   Huber, Bruno C ^a,b   Lee, Won Hee ^a   Kodo, Kazuki ^a   Ebert, Antje D ^a   Ma, Yu ^a   Nguyen, Patricia K ^a   Diecke, Sebastian ^a   Chen, Wen Yi ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

cell transplantation; molecular imaging; myocardial infarction; myocytes cardiac; paracrine communication; stem cells

Indexed keywords

FIREFLY LUCIFERASE; GREEN FLUORESCENT PROTEIN; TROPONIN;

ACUTE HEART INFARCTION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; ENGRAFTMENT; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LASER CAPTURE MICRODISSECTION; MICROFLUIDICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE CELL ANALYSIS; SKIN FIBROBLAST; STEM CELL TRANSPLANTATION; TISSUE FIXATION; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; INDUCED PLURIPOTENT STEM CELL; MYOCARDIAL INFARCTION; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; SCID MOUSE; TRANSPLANTATION;

ANIMALS; CELL LINE; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICROFLUIDICS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RANDOM ALLOCATION; SINGLE-CELL ANALYSIS; STEM CELL TRANSPLANTATION;

EID: 84940652524     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.015231     Document Type: Article

References (39)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J., Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010 121 e46 e215
2. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS., Long-Term trends in the incidence of heart failure after myocardial infarction. Circulation 2008 118 2057 2062. doi: 10.1161/CIRCULATIONAHA.108.784215
3. Matsa E, Sallam K, Wu JC., Cardiac stem cell biology: glimpse of the past, present, and future. Circ Res 2014 114 21 27. doi: 10.1161/CIRCRESAHA.113.302895
4. Wollert KC, Drexler H., Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010 7 204 215. doi: 10.1038/nrcardio.2010.1
5. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE., Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006 14 840 850. doi: 10.1016/j.ymthe.2006.05.016
6. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W., A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009 54 2277 2286. doi: 10.1016/j.jacc.2009.06.055
7. Bolli R, Chugh AR, D'Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P., Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011 378 1847 1857. doi: 10.1016/S0140-6736(11)61590-0
8. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E., Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012 379 895 904. doi: 10.1016/S0140-6736(12)60195-0
9. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007 25 1015 1024. doi: 10.1038/nbt1327
10. Shiba Y, Fernandes S, Zhu WZ, Filice D, Muskheli V, Kim J, Palpant NJ, Gantz J, Moyes KW, Reinecke H, Van Biber B, Dardas T, Mignone JL, Izawa A, Hanna R, Viswanathan M, Gold JD, Kotlikoff MI, Sarvazyan N, Kay MW, Murry CE, Laflamme MA., Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012 489 322 325. doi: 10.1038/nature11317
11. Miao Q, Shim W, Tee N, Lim SY, Chung YY, Ja KP, Ooi TH, Tan G, Kong G, Wei H, Lim CH, Sin YK, Wong P., iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium. J Cell Mol Med 2014 18 1644 1654. doi: 10.1111/jcmm.12351
12. Chen IY, Wu JC., Cardiovascular molecular imaging: focus on clinical translation. Circulation 2011 123 425 443. doi: 10.1161/CIRCULATIONAHA.109.916338
13. Laflamme MA, Murry CE., Heart regeneration. Nature 2011 473 326 335. doi: 10.1038/nature10147
14. Lalit PA, Hei DJ, Raval AN, Kamp TJ., Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res 2014 114 1328 1345. doi: 10.1161/CIRCRESAHA.114.300556
15. Gu M, Nguyen PK, Lee AS, Xu D, Hu S, Plews JR, Han L, Huber BC, Lee WH, Gong Y, de Almeida PE, Lyons J, Ikeno F, Pacharinsak C, Connolly AJ, Gambhir SS, Robbins RC, Longaker MT, Wu JC., Microfluidic single-cell analysis shows that porcine induced pluripotent stem cell-derived endothelial cells improve myocardial function by paracrine activation. Circ Res 2012 111 882 893. doi: 10.1161/CIRCRESAHA.112.269001
16. Narsinh KH, Sun N, Sanchez-Freire V, Lee AS, Almeida P, Hu S, Jan T, Wilson KD, Leong D, Rosenberg J, Yao M, Robbins RC, Wu JC., Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest 2011 121 1217 1221. doi: 10.1172/JCI44635
17. Huang M, Nguyen P, Jia F, Hu S, Gong Y, de Almeida PE, Wang L, Nag D, Kay MA, Giaccia AJ, Robbins RC, Wu JC., Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 2011 124 suppl S46 S54. doi: 10.1161/CIRCULATIONAHA.110.014019
18. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, Jia F, Hu S, Cherry AM, Robbins RC, Longaker MT, Wu JC., Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 2009 106 15720 15725. doi: 10.1073/pnas.0908450106
19. Lan F, Lee AS, Liang P, Sanchez-Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, Abilez OJ, Hu S, Ebert AD, Navarrete EG, Simmons CS, Wheeler M, Pruitt B, Lewis R, Yamaguchi Y, Ashley EA, Bers DM, Robbins RC, Longaker MT, Wu JC., Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 2013 12 101 113. doi: 10.1016/j.stem.2012.10.010
20. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, Wagner R, Lee GO, Antosiewicz-Bourget J, Teng JM, Thomson JA., Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011 8 424 429. doi: 10.1038/nmeth.1593
21. Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, Raval KK, Zhang J, Kamp TJ, Palecek SP., Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A 2012 109 E1848 E1857. doi: 10.1073/pnas.1200250109
22. Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, Ransohoff KJ, Burridge P, Wu JC., MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells 2013 31 259 268. doi: 10.1002/stem.1278
23. Liang P, Lan F, Lee AS, Gong T, Sanchez-Freire V, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, Nguyen PK, Bers DM, Robbins RC, Wu JC., Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 2013 127 1677 1691. doi: 10.1161/CIRCULATIONAHA.113.001883
24. Huber BC, Ransohoff JD, Ransohoff KJ, Riegler J, Ebert A, Kodo K, Gong Y, Sanchez-Freire V, Dey D, Kooreman NG, Diecke S, Zhang WY, Odegaard J, Hu S, Gold JD, Robbins RC, Wu JC., Costimulation-Adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation. Stem Cells 2013 31 2354 2363. doi: 10.1002/stem.1501
25. Ong SG, Lee WH, Huang M, Dey D, Kodo K, Sanchez-Freire V, Gold JD, Wu JC., Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation 2014 130 suppl 1 S60 S69. doi: 10.1161/CIRCULATIONAHA.113.007917
26. Sheikh AY, Huber BC, Narsinh KH, Spin JM, van der Bogt K, de Almeida PE, Ransohoff KJ, Kraft DL, Fajardo G, Ardigo D, Ransohoff J, Bernstein D, Fischbein MP, Robbins RC, Wu JC., In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium. Arterioscler Thromb Vasc Biol 2012 32 92 102. doi: 10.1161/ATVBAHA.111.238618
27. Cao F, Lin S, Xie X, Ray P, Patel M, Zhang X, Drukker M, Dylla SJ, Connolly AJ, Chen X, Weissman IL, Gambhir SS, Wu JC., In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 2006 113 1005 1014. doi: 10.1161/CIRCULATIONAHA.105.588954
28. Sanchez-Freire V, Ebert AD, Kalisky T, Quake SR, Wu JC., Microfluidic single-cell real-Time PCR for comparative analysis of gene expression patterns. Nat Protoc 2012 7 829 838. doi: 10.1038/nprot.2012.021
29. Hamacher-Brady A, Brady NR, Gottlieb RA., Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006 281 29776 29787. doi: 10.1074/jbc.M603783200
30. Burridge PW, Keller G, Gold JD, Wu JC., Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 2012 10 16 28. doi: 10.1016/j.stem.2011.12.013
31. Ong SG, Wu JC., Cortical bone-derived stem cells: a novel class of cells for myocardial protection. Circ Res 2013 113 480 483. doi: 10.1161/CIRCRESAHA.113.302083
32. Garbern JC, Lee RT., Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 2013 12 689 698. doi: 10.1016/j.stem.2013.05.008
33. Garber K., Inducing translation. Nat Biotechnol 2013 31 483 486. doi: 10.1038/nbt.2602
34. Davis ME, Hsieh PC, Grodzinsky AJ, Lee RT., Custom design of the cardiac microenvironment with biomaterials. Circ Res 2005 97 8 15. doi: 10.1161/01.RES.0000173376.39447.01
35. Quijada P, Toko H, Fischer KM, Bailey B, Reilly P, Hunt KD, Gude NA, Avitabile D, Sussman MA., Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells. Circ Res 2012 111 77 86. doi: 10.1161/CIRCRESAHA.112.265207
36. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ., Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003 9 1195 1201. doi: 10.1038/nm912
37. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ., Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005 11 367 368. doi: 10.1038/nm0405-367
38. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ., Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006 20 661 669. doi: 10.1096/fj.05-5211com
39. Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR., Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res 2013 113 539 552. doi: 10.1161/CIRCRESAHA.113.301202